Page last updated: 2024-10-20

pteridines and Neuroectodermal Tumors, Primitive

pteridines has been researched along with Neuroectodermal Tumors, Primitive in 1 studies

Neuroectodermal Tumors, Primitive: A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially (i.e., NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL). This term is also occasionally used as a synonym for MEDULLOBLASTOMA. In general, these tumors arise in the first decade of life and tend to be highly malignant. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmidt, C1
Schubert, NA1
Brabetz, S1
Mack, N1
Schwalm, B1
Chan, JA1
Selt, F1
Herold-Mende, C1
Witt, O1
Milde, T1
Pfister, SM1
Korshunov, A1
Kool, M1

Other Studies

1 other study available for pteridines and Neuroectodermal Tumors, Primitive

ArticleYear
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
    Neuro-oncology, 2017, Nov-29, Volume: 19, Issue:12

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Proliferation; Ch

2017